Deutsche Bank’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
NMC
GPP
GTC
B
AFM
AIC
WG
Deutsche Bank's TPST Position: Q3 2020 in Review
Deutsche Bank sold out of Tempest Therapeutics (TPST) in Q3 2020, closing a stake of 15 shares — an estimated $5K sold.
Deutsche Bank first reported a position in TPST in Q2 2013 and held it in 24 quarters. The position peaked at $3.13M in Q2 2015. 42 funds tracked by Wall St. Rank hold TPST as of Q3 2020.
- Deutsche Bank reported no remaining Tempest Therapeutics position as of Q3 2020 after selling out during the quarter.
- Deutsche Bank sold 15 Tempest Therapeutics shares in Q3 2020, an estimated $5K.
- Deutsche Bank first reported a position in Tempest Therapeutics in Q2 2013 and held it in 24 quarters.
- Deutsche Bank's Tempest Therapeutics position peaked at $3.13M in Q2 2015.
- 42 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2020.
Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.